Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21

Molecular Endocrinology
E A MusgroveR L Sutherland

Abstract

Progestin antagonists inhibit the proliferation of progesterone receptor-positive cells, including breast cancer cells, by G1 phase-specific actions, but the molecular targets involved are not defined. Reduced phosphorylation of pRB, a substrate for G1 cyclin-dependent kinases (CDKs) in vivo, was apparent after 9 h treatment of T-47D breast cancer cells with the antiprogestins RU 486 or ORG 31710, accompanying changes in S phase fraction. Although the abundance of cyclin D1, Cdk4, and Cdk6 did not decrease cyclin D1-associated kinase activity was reduced by approximately 50% at 9-18 h. Similarly, cyclin E-associated kinase activity decreased by approximately 60% at 12-24 h in the absence of significant changes in the abundance of cyclin E and Cdk2. The CDK inhibitor p21 increased in mRNA and protein abundance and was present at increased levels in cyclin D1 and cyclin E complexes at times when their kinase activity was decreased. Increased p21 protein abundance was observed in another antiprogestin-sensitive cell line, BT 474, but not in two breast cancer cell lines insensitive to antiprogestins. These data suggest increased p21 abundance and concurrent inhibition of CDK activity as a mechanism for antiprogestin induction of gr...Continue Reading

Citations

Jun 5, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alicia A GoyenecheCarlos M Telleria
Jul 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Archana ThakurD Joshua Liao
Jul 2, 2014·BioMed Research International·Liliana Germán-CastelánIgnacio Camacho-Arroyo
Nov 10, 2001·Trends in Endocrinology and Metabolism : TEM·L Altucci, H Gronemeyer
Nov 26, 2016·Nature Reviews. Cancer·Jason S CarrollWayne D Tilley
Oct 19, 2006·American Journal of Physiology. Endocrinology and Metabolism·Ruijin ShaoHåkan Billig
Apr 7, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Chih-Ping HanShun-Fa Yang
Apr 7, 1998·Molecular and Cellular Biology·E A MusgroveR L Sutherland
Nov 10, 2007·Molecular and Cellular Biology·Alessandra MagentaFabio Martelli
Jun 1, 2005·Molecular and Cellular Biology·Nicole L CollinsJoan S Brugge
Apr 7, 2010·Molecular and Cellular Biology·Zhigang YuanEdward Seto
May 5, 2020·Endocrine Reviews·Md Soriful IslamJames Segars
Aug 24, 2001·Breast Cancer Research and Treatment·K Milde-LangoschT Löning
Nov 13, 2009·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Angiolo GadducciAndrea Riccardo Genazzani
Nov 22, 2001·The Journal of Biological Chemistry·Jennifer K RicherKathryn B Horwitz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.